Objective diagnosis of alar fold collapse in active Standardbred trotting racehorses using nasopharyngeal airway pressure measurements
Equine Veterinary Journal · 2025
DOI: 10.1111/evj.14556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Equine Veterinary Journal, 2025. Verfasst von Eric Strand und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary Medicine, Norwegian University of Life Sciences (NMBU), Ås, Norway. Hauptthemen laut MEDLINE: Horse Diseases, Nasopharynx, Airway Obstruction, Laryngeal Diseases. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish-Norwegian Foundation for Equine Research, Norwegian Research Foundation.
Abstract (Originalsprache)
Background
Clinical evaluation of alar fold (AF) collapse is presently based upon subjective evaluation of improvement in breathing and respiratory noise after suturing the AFs dorsally.
Objectives
To evaluate use of nasopharyngeal airway pressure ( NAP ) as an objective method of assessing for the presence of AF collapse during exercise. NAPs should also potentially provide a precise means to grade the degree of airway obstruction present and response to surgical treatment. Study Design Prospective clinical study of actively racing Standardbred horses.
Methods
Standardbreds undergoing this test were outfitted with a heart rate monitor and warmed up on the treadmill for approximately 2000 m, prior to instrumentation with the analogue pressure sensor positioned in the nasopharynx. NAPs were measured continuously before and after the AFs were temporarily sutured dorsally, when horses were trotted at a heart rate ≥200 bpm for 2 min under identical testing circumstances. Peak inspiratory and expiratory NAPs were determined for each horse. A two‐way repeated measures ANOVA was performed to analyse the effect of suturing the AFs dorsally on inspiratory and expiratory NAPs. When possible, horses were tested again after AF resection surgery.
Results
Twenty‐one consecutive cases with suspected AF collapse were tested. Suturing the AFs dorsally had a significant effect on expiratory NAPs ( p < 0.001), but not on inspiratory NAPs. Expiratory NAPs decreased from baseline (mean ± SD) 35.8 ± 8.81 cmH 2 O to 20.1 ± 7.04 cmH 2 O after suturing AFs dorsally; to 13.3 ± 2.29 cmH 2 O after complete AF resection in 13 available horses. Main Limitations Not all horses were available for NAP testing post‐operatively.
Conclusions
NAP measurements provided a precise objective means to determine whether a horse was affected with AF collapse and assess improvement in airway function after surgery. AF collapse caused a moderate to marked expiratory airway obstruction in many affected racehorses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Veterinary Medicine, Norwegian University of Life Sciences (NMBU), Ås, Norway.
ORCID-Profile: Eric Strand, Hanna Vermedal, Hanna Margrethe Berg Olsen, Cathrine Taule Fjordbakk
Förderung
- Swedish-Norwegian Foundation for Equine Research
- Norwegian Research Foundation
Zitieren
APA
Strand, E., Vermedal, H., Olsen, H. M. B., Fjordbakk, C. T., & Fretheim-Kelly, Z. L. (2025). Objective diagnosis of alar fold collapse in active Standardbred trotting racehorses using nasopharyngeal airway pressure measurements. Equine Veterinary Journal. https://doi.org/10.1111/evj.14556
Vancouver
Strand E, Vermedal H, Olsen HMB, Fjordbakk CT, Fretheim-Kelly ZL. Objective diagnosis of alar fold collapse in active Standardbred trotting racehorses using nasopharyngeal airway pressure measurements. Equine Veterinary Journal. 2025. doi:10.1111/evj.14556
BibTeX
@article{Strand2025,
author = {Strand, Eric and Vermedal, Hanna and Olsen, Hanna Margrethe Berg and Fjordbakk, Cathrine Taule and Fretheim-Kelly, Zoe Louise},
title = {Objective diagnosis of alar fold collapse in active Standardbred trotting racehorses using nasopharyngeal airway pressure measurements},
journal = {Equine Veterinary Journal},
year = {2025},
doi = {10.1111/evj.14556}
}
EUVIMED